Back to News & Events
Company news
Financial Times Profiles Constructive Bio's Synthetic Genomics and Genetic Code Engineering
14 August 2022
The Financial Times profiled Constructive Bio's work in synthetic genomics and genetic code rewriting, covering the Cambridge company's approach to engineering organisms with expanded biological capabilities.
The Financial Times published a profile of Constructive Bio, covering the Cambridge-based company's work in synthetic genomics and its mission to engineer organisms with rewritten genetic codes for applications in biomanufacturing and therapeutics.
Read the full article:
https://www.ft.com/content/ec7563f6-c3bf-4d21-9d57-829065e22983